Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/2763
Title: Proteasome inhibitor bortezomib increases radiation sensitivity in androgen independent human prostate cancer cells
Authors: Göktaş, Serdar
Baran, Yusuf
Ural, Ali Uğur
Yazıcı, Sertaç
Aydur, Emin
Başal, Şeref
Avcu, Ferit
Pekel, Aysel
Dirican, Bahar
Beyzadeoğlu, Murat
Keywords: Androgens
Cancer chemotherapy
Cell strain DU145
Messenger RNA
Prostate cancer
Cancer cells
Issue Date: Apr-2010
Publisher: Elsevier Ltd.
Source: Göktaş, S., Baran, Y., Ural, A. U., Yazıcı, S., Aydur, E., Başal, Ş., Avcu, F., Pekel, A., Dirican, B., and Beyzadeoğlu, M. (2010). Proteasome inhibitor bortezomib increases radiation sensitivity in androgen independent human prostate cancer cells. Urology, 75(4), 793-798. doi:10.1016/j.urology.2009.07.1215
Abstract: Objectives: To investigate the effects of a strong proteasome inhibitor, bortezomib alone or in combination with radiotherapy on androgen-independent DU145 human prostate cancer cells. Proteasomes play important roles in cell cycle, proliferation, apoptosis, angiogenesis, and cellular resistance to chemotherapy and radiotherapy. Methods: Increasing concentrations of bortezomib alone or in combination with radiation were applied to DU145 cells and IC50 values that inhibited cell growth by 50% were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium-bromide assay. Apoptosis was determined using annexin V staining by flow cytometry. mRNA levels of proapoptotic caspase-3 and antiapoptotic Bcl-2 genes were examined by reverse transcriptase polymerase chain reaction. Results: The IC50 value of bortezomib was found to be 28 μm although 400- and 800-cGy radiation decreased the cell proliferation by 14% and 28%, respectively. In 400- and 800-cGy radiation applied DU145 cells, IC50 value of bortezomib decreased to 23- and 12 μm, respectively. Exposure to 5 μm bortezomib for 48 hours caused apoptosis in 35% of the population whereas 800-cGy radiation resulted apoptosis in 14% of cells. However, 42% of DU145 cells that were exposed to 800 cGy and 5 μm bortezomib underwent apoptosis. Reverse transcriptase polymerase chain reaction results showed a significant decrease in mRNA levels of antiapoptotic Bcl-2 gene and an increase in proapoptotic caspase-3 gene expression in the combination group compared to control group. Conclusions: Bortezomib increases radiation sensitivity in androgen-independent human DU145 prostate cancer cells through inhibition of Bcl-2 and induction of caspase-3 genes. © 2010 Elsevier Inc. All rights reserved.
URI: http://doi.org/10.1016/j.urology.2009.07.1215
http://hdl.handle.net/11147/2763
ISSN: 0090-4295
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File Description SizeFormat 
2763.pdfMakale258.39 kBAdobe PDFThumbnail
View/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

21
checked on Feb 16, 2024

WEB OF SCIENCETM
Citations

20
checked on Jan 27, 2024

Page view(s)

160
checked on Feb 23, 2024

Download(s)

166
checked on Feb 23, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.